Cell- and Tissue-Based TherapyCertificationConsensus
Mecide Gharibo
NPI1700968245
- Medicare services, 2017
- 116
- Part D claims, 2017
- 526
- Publications
- 11
- Clinical trials
- 1
- Industry payments
- $19,668
- Practice address
- 195 Little Albany St, New Brunswick, NJ 08901-1914
- Practice phone
- Call (732) 235-8282
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Mecide Gharibo's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Mecide Gharibo is a medical oncologist in New Brunswick, New Jersey
Mecide Gharibo practices in New Brunswick, New Jersey.
Mecide Gharibo's NPI, 1700968245, was assigned on October 20, 2006. Mecide Gharibo holds New Jersey license 25MA07091600.
NPI and contact details
- NPI
- 1700968245NPI Registry (opens in a new tab)
- NPI enumeration date
- October 20, 2006
- NPI status
- Active
- Practice phone
- (732) 235-8282
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Mecide Gharibo's practice address is in New Brunswick, New Jersey
Mecide Gharibo's practice address in the NPI Registry is 195 Little Albany St, New Brunswick, NJ 08901-1914. The practice phone is (732) 235-8282.
- NPI Registry address195 Little Albany St, New Brunswick, NJ 08901-1914Phone(732) 235-8282
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Mecide Gharibo's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Mecide Gharibo practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Mecide Gharibo's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Mecide Gharibo practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Mecide Gharibo is one of 115 medical oncologists in New Jersey
Medical oncology is Mecide Gharibo's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Mecide Gharibo is licensed in New Jersey.
Specialties and state licenses
- Medical oncology, New JerseyPrimary
Medical oncologists near Mecide Gharibo
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Mecide Gharibo billed Medicare for 116 services in 2017
CMS data shows 116 Medicare services from Mecide Gharibo across 2 procedure codes in 2017, all of them office visits. Medicare paid $11,330 for them. Every service was in an office.
Medicare services, 2017116
Paid by Medicare$11,330
Procedure codes2
Mecide Gharibo's Medicare services by type, 2016 to 2017
- 2016
- 2017
- Office and hospital visits
- 2016: 1,0022017: 11688%
- Other services
- 2016: 522017: 0100%
Mecide Gharibo compared with the New Jersey median for medical oncologists, 2017
- Mecide Gharibo
- New Jersey median
- Medicare services
- 116vs 72384% below
- Part D claims
- 526vs 35947% above
Medians across 107 medical oncologists in New Jersey with Dmand AI profiles that report each measure.
Mecide Gharibo's most billed Medicare procedure codes, 2017
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Mecide Gharibo?
Medicare shows one payer. Book a meeting to get commercial claims data for Mecide Gharibo and other medical oncologists in New Jersey.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Mecide Gharibo's patients have a median age of 74
Across all payers, Dmand AI patient panel data puts Mecide Gharibo's median patient age at 74, with 50% women.
Mecide Gharibo's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women50%
- Men50%
Source: Dmand AI Patient Panel Data
Mecide Gharibo wrote 526 Medicare Part D claims in 2017
In 2017, Mecide Gharibo wrote 526 Medicare Part D claims. They cover 15 drugs, with $1,965,306 in total drug cost. In 2016, CMS named 1,778 claims across 40 drugs.
Part D claims, 2017526
Drugs named by CMS15
Total drug cost$2M
Mecide Gharibo's most prescribed drugs by claims, 2017
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2016 to 2017
- 2016
- 2017
- Claims for drugs CMS names
- 2016: 1,7782017: 52670%
Drugs named by CMS: 15 in 2017, 40 in 2016.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find medical oncologists like Mecide Gharibo by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Mecide Gharibo has 11 publications on record
Dmand AI links 11 papers to Mecide Gharibo, published from 2016 to 2023. 2019 was the busiest year, with 3. The most frequent topics are Drug Resistance, Neoplasm and T-Lymphocytes. Mecide Gharibo's most frequent co-authors are Matthew S. Davids, MD, Elan Gorshein, DO, JD, MPH and Nicole Lamanna, MD.
Papers11
Years published2016 to 2023
Mecide Gharibo's papers by year, 2016 to 2023
Topics Mecide Gharibo writes about most
- Drug Resistance, Neoplasm
- T-Lymphocytes
Mecide Gharibo's most frequent co-authors
- Matthew S. Davids, MD2 shared papers
- Elan Gorshein, DO, JD, MPH2 shared papers
- Nicole Lamanna, MD2 shared papers
Recent publications by Mecide Gharibo
Costs and Cost AnalysisLymphoma, FollicularLymphoma, Non-Hodgkin
See who Mecide Gharibo researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Mecide Gharibo works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Mecide Gharibo has worked on 1 clinical trial
Dmand AI links Mecide Gharibo to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Multiple Myeloma and Blood Protein Disorders.
Conditions in Mecide Gharibo's trials
- Multiple Myeloma
- Blood Protein Disorders
Investigators on the most trials with Mecide Gharibo
- Rafat Abonour, MD1 shared trial
- Jeffrey Paul Allerton, MD1 shared trial
- Kathryn A. Arrambide, MD1 shared trial
Recent clinical trials with Mecide Gharibo
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma (opens in a new tab)
Active, not recruitingPhase 3
Multiple MyelomaBlood Protein DisordersBortezomibCarfilzomibDexamethasone
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Mecide Gharibo received $19,668 in industry payments from 2016 to 2018
CMS Open Payments shows 22 general payments to Mecide Gharibo from 6 drug and device companies from 2016 to 2018. Speaker and faculty fees make up the largest share, 79% of the total. Celgene Corporation paid the most, $11,157. It also lists 1 research payment totaling $1,488 in 2017.
General payments to Mecide Gharibo by program year, 2016 to 2018
General payments to Mecide Gharibo by kind, 2016 to 2018
$19.7Kin total
- Speaker and faculty fees$15,60079%
- Travel and lodging$2,08411%
- Consulting fees$1,0005%
- Food and beverage$9845%
Companies that paid Mecide Gharibo the most, 2016 to 2018
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Mecide Gharibo's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Mecide Gharibo
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Mecide Gharibo's NPI number?
Mecide Gharibo's NPI number is 1700968245. It was assigned on October 20, 2006, and it is active in the NPI Registry.
What does Mecide Gharibo specialize in?
Mecide Gharibo is a medical oncologist in New Brunswick, New Jersey. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Mecide Gharibo practice?
Mecide Gharibo practices at 195 Little Albany St, New Brunswick, NJ 08901-1914.
What is Mecide Gharibo's office phone number?
The practice phone on file for Mecide Gharibo is (732) 235-8282.
What is Mecide Gharibo's medical license number?
Mecide Gharibo holds New Jersey license 25MA07091600.
Does Mecide Gharibo accept Medicare?
Yes. CMS data shows Mecide Gharibo billed Medicare for 116 services in 2017.
What services does Mecide Gharibo bill to Medicare?
In 2017, Mecide Gharibo's most billed Medicare services were office visit, established patient (99215) and office visit, established patient (99214).
What drugs does Mecide Gharibo prescribe most?
In 2017 Medicare Part D data, Mecide Gharibo's most prescribed drugs by claims were Acyclovir, Revlimid and Ninlaro.
Has Mecide Gharibo received payments from drug or device companies?
CMS Open Payments shows $19,668 in general payments to Mecide Gharibo from 6 companies from 2016 to 2018. The largest total came from Celgene Corporation.
How long has Mecide Gharibo been practicing?
Mecide Gharibo's NPI was assigned in 2006.
Does Mecide Gharibo do research?
Dmand AI links 11 publications to Mecide Gharibo, published from 2016 to 2023. Mecide Gharibo has worked on 1 clinical trial.
Who does Mecide Gharibo publish with?
Mecide Gharibo's most frequent co-authors are Matthew S. Davids, MD (2 shared papers), Elan Gorshein, DO, JD, MPH (2 shared papers) and Nicole Lamanna, MD (2 shared papers).
Selling to medical oncology practices?
See medical oncologists in New Jersey by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card